ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
-0.17%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$73.7M
AUM Growth
+$73.7M
(-15%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-15.97%
Top 10 Holdings %
Top 10 Hldgs %
67.93%
Holding
43
New
11
Increased
8
Reduced
12
Closed
12
Top Buys
| 1 |
OPTN
OptiNose
OPTN
|
$5.68M |
| 2 |
PTC Therapeutics
PTCT
|
$3.27M |
| 3 |
Quest Diagnostics
DGX
|
$2.5M |
| 4 |
Perrigo
PRGO
|
$1.58M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$1.34M |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$3.48M |
| 2 |
Sarepta Therapeutics
SRPT
|
$3.45M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$2.84M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
$2.82M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$2.5M |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PTC Therapeutics
PTCT
$3.92B
| $9.2M | 12.49% | 551,558 +196,102 | +55% | +$3.27M |
|
|
2
Quest Diagnostics
DGX
$20.3B
| $6.27M | 8.5% | 63,610 +25,390 | +66% | +$2.5M |
|
3
Jazz Pharmaceuticals
JAZZ
$7.75B
| $6.06M | 8.22% | 44,976 +2,884 | +7% | +$388K |
|
|
OPTN
4
DELISTED
OptiNose
OPTN
| $5.68M | 7.71% | +300,618 | New | +$5.68M |
|
5
Insmed
INSM
$28.8B
| $4.94M | 6.7% | 158,277 -55,099 | -26% | -$1.72M |
|
6
Centene
CNC
$14.3B
| $4.64M | 6.3% | 46,011 -23,823 | -34% | -$2.4M |
|
7
UnitedHealth
UNH
$281B
| $4.5M | 6.11% | 20,406 -4,656 | -19% | -$1.03M |
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $3.29M | 4.47% | 13,794 -6,448 | -32% | -$1.54M |
|
9
Amicus Therapeutics
FOLD
$2.34B
| $3.07M | 4.17% | 213,413 +354 | +0.2% | +$5.09K |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.41M | 3.27% | 40,330 +22,355 | +124% | +$1.34M |
|
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $2.4M | 3.26% | 43,125 -61,941 | -59% | -$3.45M |
|
|
NVTA
12
DELISTED
Invitae Corporation
NVTA
| $1.97M | 2.67% | 216,687 -77,132 | -26% | -$701K |
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $1.92M | 2.61% | 24,795 -26,702 | -52% | -$2.07M |
|
14
Natera
NTRA
$23.1B
| $1.8M | 2.44% | 199,777 -37,341 | -16% | -$336K |
|
15
Heron Therapeutics
HRTX
$207M
| $1.8M | 2.44% | 99,181 +36,219 | +58% | +$656K |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $1.64M | 2.23% | 23,785 +11,981 | +101% | +$827K |
|
|
17
Perrigo
PRGO
$3.27B
| $1.58M | 2.14% | +18,129 | New | +$1.58M |
|
18
Teva Pharmaceuticals
TEVA
$21.1B
| $1.31M | 1.78% | +69,124 | New | +$1.31M |
|
19
Tactile Systems Technology
TCMD
$297M
| $1.25M | 1.69% | 43,089 -39,887 | -48% | -$1.16M |
|
|
SGYP
20
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.07M | 1.45% | 477,621 +206,519 | +76% | +$460K |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.06M | 1.44% | 92,518 -12,710 | -12% | -$145K |
|
22
BioMarin Pharmaceuticals
BMRN
$11.2B
| $957K | 1.3% | +10,733 | New | +$957K |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $858K | 1.16% | +25,311 | New | +$858K |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $846K | 1.15% | +66,095 | New | +$846K |
|
25
DURECT Corp
DRRX
$59.6M
| $810K | 1.1% | 878,197 -10,000 | -1% | -$9.22K |
|